SB
ELEV
Samsara BioCapital’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-830,565
| Closed | -$1.26M | – | 43 |
|
|
2023
Q2 | $1.26M | Hold |
830,565
| – | – | 0.22% | 35 |
|
|
2023
Q1 | $1.58M | Hold |
830,565
| – | – | 0.33% | 35 |
|
|
2022
Q4 | $789K | Hold |
830,565
| – | – | 0.17% | 40 |
|
|
2022
Q3 | $939K | Hold |
830,565
| – | – | 0.22% | 43 |
|
|
2022
Q2 | $1.16M | Sell |
830,565
-101,675
| -11% | -$142K | 0.31% | 42 |
|
|
2022
Q1 | $2.35M | Hold |
932,240
| – | – | 0.59% | 35 |
|
|
2021
Q4 | $5.61M | Hold |
932,240
| – | – | 1.09% | 21 |
|
|
2021
Q3 | $7.26M | Buy |
932,240
+1
| +0% | +$8 | 1.14% | 19 |
|
|
2021
Q2 | $12.7M | Buy |
+932,239
| New | +$12.7M | 1.56% | 15 |
|